G500-2020-282-GlaxoSmithKline
Simon Dawson—Bloomberg/Getty Images

Company Information

As of 8/3/2022
Country
Britain
Headquarters
Brentford, Britain
Industry
Pharmaceuticals
CEO
Emma N. Walmsley
Company Type
Public
Ticker
GSK
Revenues ($M)
$46,915
Profits ($M)
$6,030
Market Value ($M)
$87,095
Employees
90,096
Figures prepared in accordance with International Accounting Standards. Changed name from GlaxoSmithKline, May 16, 2022. Market value as of July 19, 2022.

Key Financials (Last Fiscal Year)
As of 8/3/2022

($ Millions)
% change
Revenues ($M)
$46,914.8
7.3%
Profits ($M)
$6,030.4
-18.2%
Assets ($M)
$107,129.2
-
Total Stockholder Equity ($M)
$20,389
-

Profit Ratios
As of 8/3/2022

Profit as % of Revenues
12.9%
Profits as % of Assets
5.6%
Profits as % of Stockholder Equity
29.6%

GSK Rank History

Historical Data

YearRevenues ($M)Profits ($M)Assets ($M)Total Stockholder Equity ($M)
2021$43,7321.5%$7,37324.4%$109,949$19,940
2020$43,0734.8%$5,92722.7%$105,552$15,106
2019$41,1095.8%$4,832145%$73,941$5,552
2018$38,8683.3%$1,97360.3%$76,252$-92
2017$37,6423%$1,231-90.4%$72,985$1,389
SHOW MORE
FortuneAnalytics tout
Lists ranking GSK
RANK294
Global 500 - 2022Aggregate sales hit $37.8 trillion last year—an in...READ MORE